Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Andersen, M.
Right arrow Articles by Frederick, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersen, M.
Right arrow Articles by Frederick, C. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 57, 312-325 (2000)
Copyright © 2000 by the Society of Toxicology


Respiratory Toxicology

Application of a Hybrid CFD-PBPK Nasal Dosimetry Model in an Inhalation Risk Assessment: An Example with Acrylic Acid

Melvin Andersen*, Ramesh Sarangapani{dagger}, Robinan Gentry{ddagger},1, Harvey Clewell{ddagger}, Tammie Covington{ddagger} and Clay B. Frederick§

* Colorado State University, CETT, Foothills Campus, Fort Collins, Colorado 80523; {dagger} The K. S. Crump Group, Inc., ICF Consulting, Research Triangle Park, North Carolina 27709; {ddagger} The K. S. Crump Group, Inc., ICF Consulting, Ruston, Louisiana 71270; and § Rohm & Haas Co., Spring House, Pennsylvania 19477

The available inhalation toxicity information for acrylic acid (AA) suggests that lesions to the nasal cavity, specifically olfactory degeneration, are the most sensitive end point for developing a reference concentration (RfC). Advances in physiologically based pharmacokinetic (PBPK) modeling, specifically the incorporation of computational fluid dynamic (CFD) models, now make it possible to estimate the flux of inhaled chemicals within the nasal cavity of experimental species, specifically rats. The focus of this investigation was to apply an existing CFD-PBPK hybrid model in the estimation of an RfC to determine the impact of incorporation of this new modeling technique into the risk assessment process. Information provided in the literature on the toxicity and mode of action for AA was used to determine the risk assessment approach. A comparison of the approach used for the current U.S. Environmental Protection Agency (U.S. EPA) RfC with the approach using the CFD-PBPK hybrid model was also conducted. The application of the CFD-PBPK hybrid model in a risk assessment for AA resulted in an RfC of 79 ppb, assuming a minute ventilation of 13.8 l/min (20 m3/day) in humans. This value differs substantially from the RfC of 0.37 ppb estimated for AA by the U.S. EPA before the PBPK modeling advances became available. The difference in these two RfCs arises from many factors, with the main difference being the species selected (mouse vs. rat). The choice to conduct the evaluation using the rat was based on the availability of dosimetry data in this species. Once these data are available in the mouse, an assessment should be conducted using this information. Additional differences included the methods used for estimating the target tissue concentration, the uncertainty factors (UFs) applied, and the application of duration and uncertainty adjustments to the internal target tissue dose rather than the external exposure concentration.

Key Words: acrylic acid toxicity; nasal inhalation; olfactory epithelium degeneration; interspecies dosimetry; rat; reference concentration; RfC.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
B. D. Naumann, P. A. Weideman, R. Sarangapani, S.-C. Hu, R. Dixit, and E. V. Sargent
Investigations of the Use of Bioavailability Data to Adjust Occupational Exposure Limits for Active Pharmaceutical Ingredients
Toxicol. Sci., November 1, 2009; 112(1): 196 - 210.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
G. A. Csanady and J. G. Filser
A Physiological Toxicokinetic Model for Inhaled Propylene Oxide in Rat and Human with Special Emphasis on the Nose
Toxicol. Sci., January 1, 2007; 95(1): 37 - 62.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. M. Sweeney, M. E. Andersen, and M. L. Gargas
Ethyl Acrylate Risk Assessment with a Hybrid Computational Fluid Dynamics and Physiologically Based Nasal Dosimetry Model
Toxicol. Sci., June 1, 2004; 79(2): 394 - 403.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.